Albee Messing - Publications

Affiliations: 
Comparative Biosciences University of Wisconsin, Madison, Madison, WI 
Website:
http://www.waisman.wisc.edu/FACULTY/messing.html

156 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Ashton NJ, Di Molfetta G, Tan K, Blennow K, Zetterberg H, Messing A. Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. PMID 38558318 DOI: 10.1007/s10072-024-07495-8  0.3
2024 Gammie SC, Messing A, Hill MA, Kelm-Nelson CA, Hagemann TL. Large-scale gene expression changes in APP/PSEN1 and GFAP mutation models exhibit high congruence with Alzheimer's disease. Plos One. 19: e0291995. PMID 38236817 DOI: 10.1371/journal.pone.0291995  0.324
2023 Hagemann TL, Coyne S, Levin A, Wang L, Feany MB, Messing A. STAT3 Drives GFAP Accumulation and Astrocyte Pathology in a Mouse Model of Alexander Disease. Cells. 12. PMID 37048051 DOI: 10.3390/cells12070978  0.417
2021 Boyd MM, Litscher SJ, Seitz LL, Messing A, Hagemann TL, Collier LS. Pexidartinib treatment in Alexander disease model mice reduces macrophage numbers and increases glial fibrillary acidic protein levels, yet has minimal impact on other disease phenotypes. Journal of Neuroinflammation. 18: 67. PMID 33685480 DOI: 10.1186/s12974-021-02118-x  0.435
2020 Messing A, Brenner M. GFAP at 50. Asn Neuro. 12: 1759091420949680. PMID 32811163 DOI: 10.1177/1759091420949680  0.352
2020 Helman G, Takanohashi A, Hagemann TL, Perng MD, Walkiewicz M, Woidill S, Sase S, Cross Z, Du Y, Zhao L, Waldman A, Haake BC, Fatemi A, Brenner M, Sherbini O, ... Messing A, et al. Type II Alexander disease caused by splicing errors and aberrant overexpression of an uncharacterized GFAP isoform. Human Mutation. PMID 32126152 DOI: 10.1002/Humu.24008  0.385
2019 Messing A. Refining the concept of GFAP toxicity in Alexander disease. Journal of Neurodevelopmental Disorders. 11: 27. PMID 31838996 DOI: 10.1186/S11689-019-9290-0  0.448
2018 Jones JR, Kong L, Hanna MG, Hoffman B, Krencik R, Bradley R, Hagemann T, Choi J, Doers M, Dubovis M, Sherafat MA, Bhattacharyya A, Kendziorski C, Audhya A, Messing A, et al. Mutations in GFAP Disrupt the Distribution and Function of Organelles in Human Astrocytes. Cell Reports. 25: 947-958.e4. PMID 30355500 DOI: 10.1016/J.Celrep.2018.09.083  0.421
2018 Brenner M, Messing A, Olsen ML. AP-1 and the injury response of the GFAP gene. Journal of Neuroscience Research. PMID 30345544 DOI: 10.1002/Jnr.24338  0.389
2018 Wang L, Xia J, Li J, Hagemann TL, Jones JR, Fraenkel E, Weitz DA, Zhang SC, Messing A, Feany MB. Tissue and cellular rigidity and mechanosensitive signaling activation in Alexander disease. Nature Communications. 9: 1899. PMID 29765022 DOI: 10.1038/S41467-018-04269-7  0.396
2018 Messing A. Alexander disease. Handbook of Clinical Neurology. 148: 693-700. PMID 29478608 DOI: 10.1016/B978-0-444-64076-5.00044-2  0.309
2017 Hagemann TL, Powers B, Mazur C, Kim A, Wheeler S, Hung G, Swayze E, Messing A. Antisense suppression of glial fibrillary acidic protein as a treatment for Alexander disease. Annals of Neurology. PMID 29226998 DOI: 10.1002/Ana.25118  0.475
2017 Lin NH, Messing A, Perng MD. Characterization of a panel of monoclonal antibodies recognizing specific epitopes on GFAP. Plos One. 12: e0180694. PMID 28700643 DOI: 10.1371/Journal.Pone.0180694  0.39
2017 Moody LR, Barrett-Wilt GA, Sussman MR, Messing A. Glial Fibrillary Acidic Protein Exhibits Altered Turnover Kinetics in a Mouse Model of Alexander Disease. The Journal of Biological Chemistry. PMID 28223355 DOI: 10.1074/Jbc.M116.772020  0.514
2016 Lin NH, Huang YS, Opal P, Goldman RD, Messing A, Perng MD. The role of gigaxonin in the degradation of the glial-specific intermediate filament protein GFAP. Molecular Biology of the Cell. PMID 27798231 DOI: 10.1091/Mbc.E16-06-0362  0.49
2016 Wang L, Hagemann TL, Messing A, Feany MB. An In Vivo Pharmacological Screen Identifies Cholinergic Signaling as a Therapeutic Target in Glial-Based Nervous System Disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 1445-55. PMID 26843629 DOI: 10.1523/Jneurosci.0256-15.2016  0.4
2015 Pekny M, Pekna M, Messing A, Steinhäuser C, Lee JM, Parpura V, Hol EM, Sofroniew MV, Verkhratsky A. Astrocytes: a central element in neurological diseases. Acta Neuropathologica. PMID 26671410 DOI: 10.1007/S00401-015-1513-1  0.382
2015 Wang L, Hagemann TL, Kalwa H, Michel T, Messing A, Feany MB. Nitric oxide mediates glial-induced neurodegeneration in Alexander disease. Nature Communications. 6: 8966. PMID 26608817 DOI: 10.1038/Ncomms9966  0.381
2015 Jany PL, Agosta GE, Benko WS, Eickhoff JC, Keller SR, Köehler W, Koeller D, Mar S, Naidu S, Marie Ness J, Pareyson D, Renaud DL, Salsano E, Schiffmann R, Simon J, ... ... Messing A, et al. CSF and Blood Levels of GFAP in Alexander Disease(1,2,3). Eneuro. 2. PMID 26478912 DOI: 10.1523/ENEURO.0080-15.2015  0.762
2015 LaPash Daniels CM, Paffenroth E, Austin EV, Glebov K, Lewis D, Walter J, Messing A. Lithium Decreases Glial Fibrillary Acidic Protein in a Mouse Model of Alexander Disease. Plos One. 10: e0138132. PMID 26378915 DOI: 10.1371/Journal.Pone.0138132  0.472
2015 Brenner M, Messing A. A new mutation in GFAP widens the spectrum of Alexander disease. European Journal of Human Genetics : Ejhg. 23: 1-2. PMID 24961628 DOI: 10.1038/Ejhg.2014.99  0.457
2014 Cotrina ML, Chen M, Han X, Iliff J, Ren Z, Sun W, Hagemann T, Goldman J, Messing A, Nedergaard M. Effects of traumatic brain injury on reactive astrogliosis and seizures in mouse models of Alexander disease. Brain Research. 1582: 211-9. PMID 25069089 DOI: 10.1016/J.Brainres.2014.07.029  0.386
2014 Walker AK, Daniels CM, Goldman JE, Trojanowski JQ, Lee VM, Messing A. Astrocytic TDP-43 pathology in Alexander disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 6448-58. PMID 24806671 DOI: 10.1523/Jneurosci.0248-14.2014  0.585
2013 Hagemann TL, Paylor R, Messing A. Deficits in adult neurogenesis, contextual fear conditioning, and spatial learning in a Gfap mutant mouse model of Alexander disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 18698-706. PMID 24259590 DOI: 10.1523/Jneurosci.3693-13.2013  0.433
2013 Chen MH, Hagemann TL, Quinlan RA, Messing A, Perng MD. Caspase cleavage of GFAP produces an assembly-compromised proteolytic fragment that promotes filament aggregation. Asn Neuro. 5: e00125. PMID 24102621 DOI: 10.1042/An20130032  0.41
2013 Yeo S, Bandyopadhyay S, Messing A, Brenner M. Transgenic analysis of GFAP promoter elements. Glia. 61: 1488-99. PMID 23832770 DOI: 10.1002/Glia.22536  0.419
2013 Jany PL, Hagemann TL, Messing A. GFAP expression as an indicator of disease severity in mouse models of Alexander disease. Asn Neuro. 5: e00109. PMID 23432455 DOI: 10.1042/An20130003  0.782
2013 Cunningham R, Jany P, Messing A, Li L. Protein changes in immunodepleted cerebrospinal fluid from a transgenic mouse model of Alexander disease detected using mass spectrometry. Journal of Proteome Research. 12: 719-28. PMID 23272901 DOI: 10.1021/Pr300785H  0.761
2012 Toops KA, Hagemann TL, Messing A, Nickells RW. The effect of glial fibrillary acidic protein expression on neurite outgrowth from retinal explants in a permissive environment. Bmc Research Notes. 5: 693. PMID 23259929 DOI: 10.1186/1756-0500-5-693  0.44
2012 LaPash Daniels CM, Austin EV, Rockney DE, Jacka EM, Hagemann TL, Johnson DA, Johnson JA, Messing A. Beneficial effects of Nrf2 overexpression in a mouse model of Alexander disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 10507-15. PMID 22855800 DOI: 10.1523/Jneurosci.1494-12.2012  0.49
2012 Hagemann TL, Jobe EM, Messing A. Genetic ablation of Nrf2/antioxidant response pathway in Alexander disease mice reduces hippocampal gliosis but does not impact survival. Plos One. 7: e37304. PMID 22693571 DOI: 10.1371/Journal.Pone.0037304  0.471
2012 Flint D, Li R, Webster LS, Naidu S, Kolodny E, Percy A, van der Knaap M, Powers JM, Mantovani JF, Ekstein J, Goldman JE, Messing A, Brenner M. Splice site, frameshift, and chimeric GFAP mutations in Alexander disease. Human Mutation. 33: 1141-8. PMID 22488673 DOI: 10.1002/Humu.22094  0.402
2012 Verkhratsky A, Sofroniew MV, Messing A, deLanerolle NC, Rempe D, Rodríguez JJ, Nedergaard M. Neurological diseases as primary gliopathies: a reassessment of neurocentrism. Asn Neuro. 4. PMID 22339481 DOI: 10.1042/An20120010  0.388
2012 Messing A, Li R, Naidu S, Taylor JP, Silverman L, Flint D, van der Knaap MS, Brenner M. Archetypal and new families with Alexander disease and novel mutations in GFAP. Archives of Neurology. 69: 208-14. PMID 21987397 DOI: 10.1001/Archneurol.2011.1181  0.33
2011 Prust M, Wang J, Morizono H, Messing A, Brenner M, Gordon E, Hartka T, Sokohl A, Schiffmann R, Gordish-Dressman H, Albin R, Amartino H, Brockman K, Dinopoulos A, Dotti MT, et al. GFAP mutations, age at onset, and clinical subtypes in Alexander disease. Neurology. 77: 1287-94. PMID 21917775 DOI: 10.1212/Wnl.0B013E3182309F72  0.352
2011 Duarri A, Lopez de Heredia M, Capdevila-Nortes X, Ridder MC, Montolio M, López-Hernández T, Boor I, Lien CF, Hagemann T, Messing A, Gorecki DC, Scheper GC, Martínez A, Nunes V, van der Knaap MS, et al. Knockdown of MLC1 in primary astrocytes causes cell vacuolation: a MLC disease cell model. Neurobiology of Disease. 43: 228-38. PMID 21440627 DOI: 10.1016/J.Nbd.2011.03.015  0.453
2011 Fratta P, Saveri P, Zambroni D, Ferri C, Tinelli E, Messing A, D'Antonio M, Feltri ML, Wrabetz L. P0S63del impedes the arrival of wild-type P0 glycoprotein to myelin in CMT1B mice. Human Molecular Genetics. 20: 2081-90. PMID 21363884 DOI: 10.1093/Hmg/Ddr081  0.489
2011 Cengiz P, Kleman N, Uluc K, Kendigelen P, Hagemann T, Akture E, Messing A, Ferrazzano P, Sun D. Inhibition of Na+/H+ exchanger isoform 1 is neuroprotective in neonatal hypoxic ischemic brain injury. Antioxidants & Redox Signaling. 14: 1803-13. PMID 20712402 DOI: 10.1089/Ars.2010.3468  0.333
2010 Yang JH, Wada A, Yoshida K, Miyoshi Y, Sayano T, Esaki K, Kinoshita MO, Tomonaga S, Azuma N, Watanabe M, Hamase K, Zaitsu K, Machida T, Messing A, Itohara S, et al. Brain-specific Phgdh deletion reveals a pivotal role for L-serine biosynthesis in controlling the level of D-serine, an N-methyl-D-aspartate receptor co-agonist, in adult brain. The Journal of Biological Chemistry. 285: 41380-90. PMID 20966073 DOI: 10.1074/Jbc.M110.187443  0.301
2010 Messing A, LaPash Daniels CM, Hagemann TL. Strategies for treatment in Alexander disease. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 7: 507-15. PMID 20880512 DOI: 10.1016/J.Nurt.2010.05.013  0.45
2010 Meisingset TW, Risa Ø, Brenner M, Messing A, Sonnewald U. Alteration of glial-neuronal metabolic interactions in a mouse model of Alexander disease. Glia. 58: 1228-34. PMID 20544858 DOI: 10.1002/Glia.21003  0.425
2010 Cho W, Brenner M, Peters N, Messing A. Drug screening to identify suppressors of GFAP expression. Human Molecular Genetics. 19: 3169-78. PMID 20538881 DOI: 10.1093/Hmg/Ddq227  0.64
2010 Tian R, Wu X, Hagemann TL, Sosunov AA, Messing A, McKhann GM, Goldman JE. Alexander disease mutant glial fibrillary acidic protein compromises glutamate transport in astrocytes. Journal of Neuropathology and Experimental Neurology. 69: 335-45. PMID 20448479 DOI: 10.1097/Nen.0B013E3181D3Cb52  0.428
2009 Liem RK, Messing A. Dysfunctions of neuronal and glial intermediate filaments in disease. The Journal of Clinical Investigation. 119: 1814-24. PMID 19587456 DOI: 10.1172/Jci38003  0.412
2009 Cho W, Hagemann TL, Johnson DA, Johnson JA, Messing A. Dual transgenic reporter mice as a tool for monitoring expression of glial fibrillary acidic protein. Journal of Neurochemistry. 110: 343-51. PMID 19457099 DOI: 10.1111/J.1471-4159.2009.06146.X  0.674
2009 Cho W, Messing A. Properties of astrocytes cultured from GFAP over-expressing and GFAP mutant mice. Experimental Cell Research. 315: 1260-72. PMID 19146851 DOI: 10.1016/J.Yexcr.2008.12.012  0.665
2009 Hagemann TL, Boelens WC, Wawrousek EF, Messing A. Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease. Human Molecular Genetics. 18: 1190-9. PMID 19129171 DOI: 10.1093/Hmg/Ddp013  0.501
2008 Vargas MR, Johnson DA, Sirkis DW, Messing A, Johnson JA. Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 13574-81. PMID 19074031 DOI: 10.1523/Jneurosci.4099-08.2008  0.398
2008 Tang G, Yue Z, Talloczy Z, Hagemann T, Cho W, Messing A, Sulzer DL, Goldman JE. Autophagy induced by Alexander disease-mutant GFAP accumulation is regulated by p38/MAPK and mTOR signaling pathways. Human Molecular Genetics. 17: 1540-55. PMID 18276609 DOI: 10.1093/Hmg/Ddn042  0.622
2008 Lee Y, Messing A, Su M, Brenner M. GFAP promoter elements required for region-specific and astrocyte-specific expression. Glia. 56: 481-93. PMID 18240313 DOI: 10.1002/Glia.20622  0.434
2007 Zou W, Kim BO, Zhou BY, Liu Y, Messing A, He JJ. Protection against human immunodeficiency virus type 1 Tat neurotoxicity by Ginkgo biloba extract EGb 761 involving glial fibrillary acidic protein. The American Journal of Pathology. 171: 1923-35. PMID 18055541 DOI: 10.2353/Ajpath.2007.070333  0.405
2007 Brew HM, Gittelman JX, Silverstein RS, Hanks TD, Demas VP, Robinson LC, Robbins CA, McKee-Johnson J, Chiu SY, Messing A, Tempel BL. Seizures and reduced life span in mice lacking the potassium channel subunit Kv1.2, but hypoexcitability and enlarged Kv1 currents in auditory neurons. Journal of Neurophysiology. 98: 1501-25. PMID 17634333 DOI: 10.1152/Jn.00640.2006  0.353
2007 Quinlan RA, Brenner M, Goldman JE, Messing A. GFAP and its role in Alexander disease. Experimental Cell Research. 313: 2077-87. PMID 17498694 DOI: 10.1016/J.Yexcr.2007.04.004  0.358
2006 Hagemann TL, Connor JX, Messing A. Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 11162-73. PMID 17065456 DOI: 10.1523/Jneurosci.3260-06.2006  0.807
2006 Triolo D, Dina G, Lorenzetti I, Malaguti M, Morana P, Del Carro U, Comi G, Messing A, Quattrini A, Previtali SC. Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage. Journal of Cell Science. 119: 3981-93. PMID 16988027 DOI: 10.1242/Jcs.03168  0.357
2006 Jeng LJ, Balice-Gordon RJ, Messing A, Fischbeck KH, Scherer SS. The effects of a dominant connexin32 mutant in myelinating Schwann cells. Molecular and Cellular Neurosciences. 32: 283-98. PMID 16790356 DOI: 10.1016/J.Mcn.2006.05.001  0.478
2006 Barkovich AJ, Messing A. Alexander disease: not just a leukodystrophy anymore. Neurology. 66: 468-9. PMID 16505295 DOI: 10.1212/01.Wnl.0000200905.43191.4D  0.338
2006 de Leeuw B, Su M, ter Horst M, Iwata S, Rodijk M, Hoeben RC, Messing A, Smitt PS, Brenner M. Increased glia-specific transgene expression with glial fibrillary acidic protein promoters containing multiple enhancer elements. Journal of Neuroscience Research. 83: 744-53. PMID 16496373 DOI: 10.1002/Jnr.20776  0.412
2006 Wrabetz L, D'Antonio M, Pennuto M, Dati G, Tinelli E, Fratta P, Previtali S, Imperiale D, Zielasek J, Toyka K, Avila RL, Kirschner DA, Messing A, Feltri ML, Quattrini A. Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 2358-68. PMID 16495463 DOI: 10.1523/Jneurosci.3819-05.2006  0.474
2006 Lee Y, Su M, Messing A, Brenner M. Astrocyte heterogeneity revealed by expression of a GFAP-LacZ transgene. Glia. 53: 677-87. PMID 16482522 DOI: 10.1002/Glia.20320  0.453
2006 Li R, Johnson AB, Salomons GS, van der Knaap MS, Rodriguez D, Boespflug-Tanguy O, Gorospe JR, Goldman JE, Messing A, Brenner M. Propensity for paternal inheritance of de novo mutations in Alexander disease. Human Genetics. 119: 137-44. PMID 16365765 DOI: 10.1007/S00439-005-0116-7  0.322
2005 Zhu Y, Guignard F, Zhao D, Liu L, Burns DK, Mason RP, Messing A, Parada LF. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell. 8: 119-30. PMID 16098465 DOI: 10.1016/J.Ccr.2005.07.004  0.312
2005 Jacobs EC, Pribyl TM, Feng JM, Kampf K, Spreur V, Campagnoni C, Colwell CS, Reyes SD, Martin M, Handley V, Hiltner TD, Readhead C, Jacobs RE, Messing A, Fisher RS, et al. Region-specific myelin pathology in mice lacking the golli products of the myelin basic protein gene. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 7004-13. PMID 16049176 DOI: 10.1523/Jneurosci.0288-05.2005  0.4
2005 Hagemann TL, Gaeta SA, Smith MA, Johnson DA, Johnson JA, Messing A. Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction. Human Molecular Genetics. 14: 2443-58. PMID 16014634 DOI: 10.1093/Hmg/Ddi248  0.489
2005 Yue Q, Groszer M, Gil JS, Berk AJ, Messing A, Wu H, Liu X. PTEN deletion in Bergmann glia leads to premature differentiation and affects laminar organization. Development (Cambridge, England). 132: 3281-91. PMID 15944184 DOI: 10.1242/Dev.01891  0.302
2005 van der Knaap MS, Salomons GS, Li R, Franzoni E, Gutiérrez-Solana LG, Smit LM, Robinson R, Ferrie CD, Cree B, Reddy A, Thomas N, Banwell B, Barkhof F, Jakobs C, Johnson A, ... Messing A, et al. Unusual variants of Alexander's disease. Annals of Neurology. 57: 327-38. PMID 15732098 DOI: 10.1002/Ana.20381  0.317
2005 Li R, Johnson AB, Salomons G, Goldman JE, Naidu S, Quinlan R, Cree B, Ruyle SZ, Banwell B, D'Hooghe M, Siebert JR, Rolf CM, Cox H, Reddy A, Gutiérrez-Solana LG, ... ... Messing A, et al. Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Annals of Neurology. 57: 310-26. PMID 15732097 DOI: 10.1002/Ana.20406  0.426
2005 Connor JX, McCormack K, Pletsch A, Gaeta S, Ganetzky B, Chiu SY, Messing A. Genetic modifiers of the Kv beta2-null phenotype in mice. Genes, Brain, and Behavior. 4: 77-88. PMID 15720404 DOI: 10.1111/J.1601-183X.2004.00094.X  0.752
2005 Scherer SS, Xu YT, Messing A, Willecke K, Fischbeck KH, Jeng LJ. Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 1550-9. PMID 15703409 DOI: 10.1523/Jneurosci.3082-04.2005  0.513
2004 Su M, Hu H, Lee Y, d'Azzo A, Messing A, Brenner M. Expression specificity of GFAP transgenes. Neurochemical Research. 29: 2075-93. PMID 15662842 DOI: 10.1007/S11064-004-6881-1  0.412
2004 Anton ES, Ghashghaei HT, Weber JL, McCann C, Fischer TM, Cheung ID, Gassmann M, Messing A, Klein R, Schwab MH, Lloyd KC, Lai C. Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain. Nature Neuroscience. 7: 1319-28. PMID 15543145 DOI: 10.1038/Nn1345  0.309
2004 Taveggia C, Pizzagalli A, Fagiani E, Messing A, Feltri ML, Wrabetz L. Characterization of a Schwann cell enhancer in the myelin basic protein gene. Journal of Neurochemistry. 91: 813-24. PMID 15525335 DOI: 10.1111/J.1471-4159.2004.02745.X  0.403
2004 Smith SR, Cooperman S, Lavaute T, Tresser N, Ghosh M, Meyron-Holtz E, Land W, Ollivierre H, Jortner B, Switzer R, Messing A, Rouault TA. Severity of neurodegeneration correlates with compromise of iron metabolism in mice with iron regulatory protein deficiencies. Annals of the New York Academy of Sciences. 1012: 65-83. PMID 15105256 DOI: 10.1196/Annals.1306.006  0.423
2004 Yin X, Kidd GJ, Pioro EP, McDonough J, Dutta R, Feltri ML, Wrabetz L, Messing A, Wyatt RM, Balice-Gordon RJ, Trapp BD. Dysmyelinated lower motor neurons retract and regenerate dysfunctional synaptic terminals. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 3890-8. PMID 15084670 DOI: 10.1523/Jneurosci.4617-03.2004  0.306
2003 Messing A, Brenner M. Alexander disease: GFAP mutations unify young and old. The Lancet. Neurology. 2: 75. PMID 12849260 DOI: 10.1016/S1474-4422(03)00301-6  0.359
2003 Voskuhl RR, Pribyl TM, Kampf K, Handley V, Liu HB, Feng J, Campagnoni CW, Soldan SS, Messing A, Campagnoni AT. Experimental autoimmune encephalomyelitis relapses are reduced in heterozygous golli MBP knockout mice. Journal of Neuroimmunology. 139: 44-50. PMID 12799019 DOI: 10.1016/S0165-5728(03)00161-9  0.467
2003 Saito F, Moore SA, Barresi R, Henry MD, Messing A, Ross-Barta SE, Cohn RD, Williamson RA, Sluka KA, Sherman DL, Brophy PJ, Schmelzer JD, Low PA, Wrabetz L, Feltri ML, et al. Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization. Neuron. 38: 747-58. PMID 12797959 DOI: 10.1016/S0896-6273(03)00301-5  0.361
2003 Messing A, Brenner M. GFAP: functional implications gleaned from studies of genetically engineered mice. Glia. 43: 87-90. PMID 12761871 DOI: 10.1002/Glia.10219  0.513
2003 Theis M, Jauch R, Zhuo L, Speidel D, Wallraff A, Döring B, Frisch C, Söhl G, Teubner B, Euwens C, Huston J, Steinhäuser C, Messing A, Heinemann U, Willecke K. Accelerated hippocampal spreading depression and enhanced locomotory activity in mice with astrocyte-directed inactivation of connexin43. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 766-76. PMID 12574405 DOI: 10.1523/Jneurosci.23-03-00766.2003  0.478
2003 Feltri M, Saito F, Moore S, Nodari A, Previtali S, Quattrini A, Messing A, Campbell K, Wrabetz L. Abstracts of the 8th Meeting of the Italian Peripheral Nerve Study Group: 23 Journal of the Peripheral Nervous System. 8: 29-58. DOI: 10.1046/J.1529-8027.2003.00034.X  0.415
2003 Dati G, Quattrini A, Dina G, D’Antonio M, Fratta P, Messing A, Feltri M, Wrabetz L. Abstracts of the 8th Meeting of the Italian Peripheral Nerve Study Group: 15 Journal of the Peripheral Nervous System. 8: 29-58. DOI: 10.1046/J.1529-8027.2003.00015.X  0.499
2002 Li R, Messing A, Goldman JE, Brenner M. GFAP mutations in Alexander disease. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 20: 259-68. PMID 12175861 DOI: 10.1016/S0736-5748(02)00019-9  0.477
2002 Moore SA, Saito F, Chen J, Michele DE, Henry MD, Messing A, Cohn RD, Ross-Barta SE, Westra S, Williamson RA, Hoshi T, Campbell KP. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature. 418: 422-5. PMID 12140559 DOI: 10.1038/Nature00838  0.397
2002 Gorospe JR, Naidu S, Johnson AB, Puri V, Raymond GV, Jenkins SD, Pedersen RC, Lewis D, Knowles P, Fernandez R, De Vivo D, van der Knaap MS, Messing A, Brenner M, Hoffman EP. Molecular findings in symptomatic and pre-symptomatic Alexander disease patients. Neurology. 58: 1494-500. PMID 12034785 DOI: 10.1212/Wnl.58.10.1494  0.388
2002 McCormack K, Connor JX, Zhou L, Ho LL, Ganetzky B, Chiu SY, Messing A. Genetic analysis of the mammalian K+ channel beta subunit Kvbeta 2 (Kcnab2). The Journal of Biological Chemistry. 277: 13219-28. PMID 11825900 DOI: 10.1074/Jbc.M111465200  0.782
2002 Feltri ML, Graus Porta D, Previtali SC, Nodari A, Migliavacca B, Cassetti A, Littlewood-Evans A, Reichardt LF, Messing A, Quattrini A, Mueller U, Wrabetz L. Conditional disruption of beta 1 integrin in Schwann cells impedes interactions with axons. The Journal of Cell Biology. 156: 199-209. PMID 11777940 DOI: 10.1083/Jcb.200109021  0.351
2001 Zhuo L, Theis M, Alvarez-Maya I, Brenner M, Willecke K, Messing A. hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. Genesis (New York, N.Y. : 2000). 31: 85-94. PMID 11668683 DOI: 10.1002/Gene.10008  0.46
2001 Rodriguez D, Gauthier F, Bertini E, Bugiani M, Brenner M, N'guyen S, Goizet C, Gelot A, Surtees R, Pedespan JM, Hernandorena X, Troncoso M, Uziel G, Messing A, Ponsot G, et al. Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation. American Journal of Human Genetics. 69: 1134-40. PMID 11567214 DOI: 10.1086/323799  0.374
2001 Messing A, Goldman JE, Johnson AB, Brenner M. Alexander disease: new insights from genetics. Journal of Neuropathology and Experimental Neurology. 60: 563-73. PMID 11398833 DOI: 10.1093/Jnen/60.6.563  0.364
2001 Brenner M, Johnson AB, Boespflug-Tanguy O, Rodriguez D, Goldman JE, Messing A. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nature Genetics. 27: 117-20. PMID 11138011 DOI: 10.1038/83679  0.481
2001 Wrabetz L, D'Antonio M, Quattrini A, Dati G, Fratta P, Fasolini M, Zielasek J, Toyka K, Messing A, Feltri M. Morphological And Electrophysiological Signs Of Dysmyelination In Transgenic Mice Expressing CMT1B ( MPZ    DELSer34 ) or DSS ( MPZ    Ser34Cys ) Mutations Journal of the Peripheral Nervous System. 6: 58-59. DOI: 10.1046/J.1529-8027.2001.01007-53.X  0.481
2001 Feltri M, Quattrini A, Previtali S, Nodari A, Migliavacca B, Graus‐Porta D, Littlewood‐Evans A, Messing A, Mueller U, Wrabetz L. αβ1 Integrins Are Required For Normal Peripheral Nerve Development Journal of the Peripheral Nervous System. 6: 48-48. DOI: 10.1046/J.1529-8027.2001.01007-23.X  0.392
2000 Previtali SC, Quattrini A, Fasolini M, Panzeri MC, Villa A, Filbin MT, Li W, Chiu SY, Messing A, Wrabetz L, Feltri ML. Epitope-tagged P(0) glycoprotein causes Charcot-Marie-Tooth-like neuropathy in transgenic mice. The Journal of Cell Biology. 151: 1035-46. PMID 11086005 DOI: 10.1083/Jcb.151.5.1035  0.432
2000 Wrabetz L, Feltri ML, Quattrini A, Imperiale D, Previtali S, D'Antonio M, Martini R, Yin X, Trapp BD, Zhou L, Chiu SY, Messing A. P(0) glycoprotein overexpression causes congenital hypomyelination of peripheral nerves. The Journal of Cell Biology. 148: 1021-34. PMID 10704451 DOI: 10.1083/Jcb.148.5.1021  0.401
2000 Yin X, Kidd GJ, Wrabetz L, Feltri ML, Messing A, Trapp BD. Schwann cell myelination requires timely and precise targeting of P(0) protein. The Journal of Cell Biology. 148: 1009-20. PMID 10704450 DOI: 10.1083/Jcb.148.5.1009  0.342
2000 Gonatas JO, Stieber A, Gonatas NK, Messing A. The golgi apparatus is present in perisynaptic, subependymal and perivascular processes of astrocytes and in processes of retinal Müller glia. Brain Research. 855: 23-31. PMID 10650126 DOI: 10.1016/S0006-8993(99)02037-5  0.528
2000 Previtali S, Quattrini A, Imperiale D, Canal N, Trapp B, Messing A, Feltri M, Wrabetz L. PATHOGENESIS OF CONGENITAL HYPOMYELINATION REVEALED BY P0 OVEREXPRESSING MICE Journal of the Peripheral Nervous System. 5: 47-47. DOI: 10.1046/J.1529-8027.2000.00513-47.X  0.443
2000 Feltri M, Quattrini A, D'antonio M, Imperiale D, Dati G, Previtali S, Canal N, Messing A, Wrabetz L. TRANSGENIC MOUSE MODELS OF CHARCOT‐MARIE‐TOOTH 1b Journal of the Peripheral Nervous System. 5: 39-39. DOI: 10.1046/J.1529-8027.2000.00513-22.X  0.309
1999 Quattrini A, Feltri ML, Previtali S, Fasolini M, Messing A, Wrabetz L. Peripheral Nerve Dysmyelination Due to P0 Glycoprotein Overexpression Is Dose-Dependent. Annals of the New York Academy of Sciences. 883: 294-301. PMID 29086950 DOI: 10.1111/J.1749-6632.1999.Tb08591.X  0.437
1999 Feltri ML, D'Antonio M, Previtali S, Fasolini M, Messing A, Wrabetz L. P0-Cre Transgenic Mice for Inactivation of Adhesion Molecules in Schwann Cells. Annals of the New York Academy of Sciences. 883: 116-123. PMID 29086916 DOI: 10.1111/J.1749-6632.1999.Tb08574.X  0.392
1999 Arroyo EJ, Xu YT, Zhou L, Messing A, Peles E, Chiu SY, Scherer SS. Myelinating Schwann cells determine the internodal localization of Kv1.1, Kv1.2, Kvbeta2, and Caspr. Journal of Neurocytology. 28: 333-47. PMID 10739575 DOI: 10.1023/A:1007009613484  0.362
1999 Quattrini A, Feltri ML, Previtali S, Fasolini M, Messing A, Wrabetz L. Peripheral nerve dysmyelination due to P0 glycoprotein overexpression is dose-dependent. Annals of the New York Academy of Sciences. 883: 294-301. PMID 10586254  0.328
1999 Abel A, Bone LJ, Messing A, Scherer SS, Fischbeck KH. Studies in transgenic mice indicate a loss of connexin32 function in X-linked Charcot-Marie-Tooth disease. Journal of Neuropathology and Experimental Neurology. 58: 702-10. PMID 10411340 DOI: 10.1097/00005072-199907000-00004  0.465
1999 Zhou L, Messing A, Chiu SY. Determinants of excitability at transition zones in Kv1.1-deficient myelinated nerves. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 5768-81. PMID 10407018 DOI: 10.1523/Jneurosci.19-14-05768.1999  0.36
1999 Feltri ML, D'antonio M, Quattrini A, Numerato R, Arona M, Previtali S, Chiu SY, Messing A, Wrabetz L. A novel P0 glycoprotein transgene activates expression of lacZ in myelin-forming Schwann cells. The European Journal of Neuroscience. 11: 1577-86. PMID 10215910 DOI: 10.1046/J.1460-9568.1999.00568.X  0.427
1999 Zhang CL, Messing A, Chiu SY. Specific alteration of spontaneous GABAergic inhibition in cerebellar purkinje cells in mice lacking the potassium channel Kv1. 1. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 2852-64. PMID 10191303 DOI: 10.1523/Jneurosci.19-08-02852.1999  0.381
1999 Xu K, Malouf AT, Messing A, Silver J. Glial fibrillary acidic protein is necessary for mature astrocytes to react to beta-amyloid. Glia. 25: 390-403. PMID 10028921 DOI: 10.1002/(Sici)1098-1136(19990215)25:4<390::Aid-Glia8>3.0.Co;2-7  0.44
1999 Wakabayashi T, Messing A, Brenner M. Nonlethal detection of transgene expression in the CNS of founder mice. Biotechniques. 26: 302-4, 306-7. PMID 10023542 DOI: 10.2144/99262St04  0.455
1998 Messing A. Transgenic studies of peripheral and central glia. The International Journal of Developmental Biology. 42: 1019-24. PMID 9853833  0.327
1998 Zhou L, Zhang CL, Messing A, Chiu SY. Temperature-sensitive neuromuscular transmission in Kv1.1 null mice: role of potassium channels under the myelin sheath in young nerves. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 7200-15. PMID 9736643 DOI: 10.1523/Jneurosci.18-18-07200.1998  0.367
1998 Eng LF, Lee YL, Kwan H, Brenner M, Messing A. Astrocytes cultured from transgenic mice carrying the added human glial fibrillary acidic protein gene contain Rosenthal fibers. Journal of Neuroscience Research. 53: 353-60. PMID 9698163 DOI: 10.1002/(Sici)1097-4547(19980801)53:3<353::Aid-Jnr9>3.0.Co;2-9  0.48
1998 Nawashiro H, Messing A, Azzam N, Brenner M. Mice lacking GFAP are hypersensitive to traumatic cerebrospinal injury. Neuroreport. 9: 1691-6. PMID 9665584 DOI: 10.1097/00001756-199806010-00004  0.412
1998 Smart SL, Lopantsev V, Zhang CL, Robbins CA, Wang H, Chiu SY, Schwartzkroin PA, Messing A, Tempel BL. Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron. 20: 809-19. PMID 9581771 DOI: 10.1016/S0896-6273(00)81018-1  0.334
1998 Wrabetz L, Taveggia C, Feltri ML, Quattrini A, Awatramani R, Scherer SS, Messing A, Kamholz J. A minimal human MBP promoter-lacZ transgene is appropriately regulated in developing brain and after optic enucleation, but not in shiverer mutant mice. Journal of Neurobiology. 34: 10-26. PMID 9469615 DOI: 10.1002/(Sici)1097-4695(199801)34:1<10::Aid-Neu2>3.0.Co;2-F  0.467
1998 Messing A, Head MW, Galles K, Galbreath EJ, Goldman JE, Brenner M. Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice. The American Journal of Pathology. 152: 391-8. PMID 9466565  0.451
1997 Wang X, Messing A, David S. Axonal and nonneuronal cell responses to spinal cord injury in mice lacking glial fibrillary acidic protein. Experimental Neurology. 148: 568-76. PMID 9417833 DOI: 10.1006/Exnr.1997.6702  0.437
1997 Carpenter MK, Winkler C, Fricker R, Emerich DF, Wong SC, Greco C, Chen EY, Chu Y, Kordower JH, Messing A, Björklund A, Hammang JP. Generation and transplantation of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice. Experimental Neurology. 148: 187-204. PMID 9398461 DOI: 10.1006/Exnr.1997.6657  0.339
1997 Vabnick I, Messing A, Chiu SY, Levinson SR, Schachner M, Roder J, Li C, Novakovic S, Shrager P. Sodium channel distribution in axons of hypomyelinated and MAG null mutant mice. Journal of Neuroscience Research. 50: 321-36. PMID 9373041 DOI: 10.1002/(Sici)1097-4547(19971015)50:2<321::Aid-Jnr20>3.0.Co;2-9  0.386
1997 Kordower JH, Chen EY, Winkler C, Fricker R, Charles V, Messing A, Mufson EJ, Wong SC, Rosenstein JM, Björklund A, Emerich DF, Hammang J, Carpenter MK. Grafts of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice: trophic and tropic effects in a rodent model of Huntington's disease. The Journal of Comparative Neurology. 387: 96-113. PMID 9331174 DOI: 10.1002/(Sici)1096-9861(19971013)387:1<96::Aid-Cne8>3.0.Co;2-I  0.347
1997 Peachey NS, Roveri L, Messing A, McCall MA. Functional consequences of oncogene-induced horizontal cell degeneration in the retinas of transgenic mice. Visual Neuroscience. 14: 627-32. PMID 9278992 DOI: 10.1017/S0952523800012591  0.379
1997 Zhuo L, Sun B, Zhang CL, Fine A, Chiu SY, Messing A. Live astrocytes visualized by green fluorescent protein in transgenic mice. Developmental Biology. 187: 36-42. PMID 9224672 DOI: 10.1006/Dbio.1997.8601  0.483
1997 Zhuo L, Messing A, Azen EA. Proline-rich-protein promoters direct LacZ expression to the granular convoluted tubular cells of the submandibular gland in adult transgenic mice. Transgenic Research. 6: 19-25. PMID 9032974 DOI: 10.1023/A:1018496814589  0.405
1996 Brenner M, Messing A. GFAP Transgenic Mice Methods (San Diego, Calif.). 10: 351-64. PMID 8954847 DOI: 10.1006/Meth.1996.0113  0.48
1996 Delaney CL, Brenner M, Messing A. Conditional ablation of cerebellar astrocytes in postnatal transgenic mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 6908-18. PMID 8824329 DOI: 10.1523/Jneurosci.16-21-06908.1996  0.46
1996 McCall MA, Gregg RG, Behringer RR, Brenner M, Delaney CL, Galbreath EJ, Zhang CL, Pearce RA, Chiu SY, Messing A. Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. Proceedings of the National Academy of Sciences of the United States of America. 93: 6361-6. PMID 8692820 DOI: 10.1073/Pnas.93.13.6361  0.474
1996 Schwartz JP, Taniwaki T, Messing A, Brenner M. Somatostatin as a trophic factor. Analysis of transgenic mice overexpressing somatostatin in astrocytes. Annals of the New York Academy of Sciences. 780: 29-35. PMID 8602737  0.315
1996 Messing A, Galbreath EJ, Sijapati KK, Brenner M. OVEREXPRESSION OF GFAP IN TRANSGENIC MICE Journal of Neuropathology and Experimental Neurology. 55: 620. DOI: 10.1097/00005072-199605000-00070  0.433
1995 Zhou R, Assouline JG, Abbas PJ, Messing A, Gantz BJ. Anatomical and physiological measures of auditory system in mice with peripheral myelin deficiency. Hearing Research. 88: 87-97. PMID 8576008 DOI: 10.1016/0378-5955(95)00104-C  0.46
1995 Galbreath E, Kim SJ, Park K, Brenner M, Messing A. Overexpression of TGF-beta 1 in the central nervous system of transgenic mice results in hydrocephalus. Journal of Neuropathology and Experimental Neurology. 54: 339-49. PMID 7745433 DOI: 10.1097/00005072-199505000-00007  0.352
1995 Messing A, Delaney CL, Brenner M. CONDITIONAL ABLATION OF CEREBELLAR ASTROCYTES IN TRANSGENIC MICE Journal of Neuropathology and Experimental Neurology. 54: 469. DOI: 10.1097/00005072-199505000-00249  0.424
1994 Brenner M, Kisseberth WC, Su Y, Besnard F, Messing A. GFAP promoter directs astrocyte-specific expression in transgenic mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 1030-7. PMID 8120611 DOI: 10.1523/Jneurosci.14-03-01030.1994  0.475
1994 Chiu SY, Scherer SS, Blonski M, Kang SS, Messing A. Axons regulate the expression of Shaker-like potassium channel genes in Schwann cells in peripheral nerve. Glia. 12: 1-11. PMID 7843783 DOI: 10.1002/Glia.440120102  0.35
1994 Messing A, Behringer RR, Wrabetz L, Hammang JP, Lemke G, Palmiter RD, Brinster RL. Hypomyelinating peripheral neuropathies and schwannomas in transgenic mice expressing SV40 T-antigen. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 3533-9. PMID 7515952  0.345
1994 Fung KM, Chikaraishi DM, Suri C, Theuring F, Messing A, Albert DM, Lee VM, Trojanowski JQ. Molecular phenotype of simian virus 40 large T antigen-induced primitive neuroectodermal tumors in four different lines of transgenic mice. Laboratory Investigation; a Journal of Technical Methods and Pathology. 70: 114-24. PMID 7508007  0.605
1994 Cole J, Messing A, Trojanowski J, Lee V. Modulation of axon diameter and neurofilaments by hypomyelinating Schwann cells in transgenic mice The Journal of Neuroscience. 14: 6956-6966. DOI: 10.1523/Jneurosci.14-11-06956.1994  0.461
1994 Messing A, Behringer R, Wrabetz L, Hammang J, Lemke G, Palmiter R, Brinster R. Hypomyelinating peripheral neuropathies and schwannomas in transgenic mice expressing SV40 T-antigen The Journal of Neuroscience. 14: 3533-3539. DOI: 10.1523/Jneurosci.14-06-03533.1994  0.451
1994 Hammang JP, Reynolds BA, Weiss S, Messing A, Duncan ID. Transplantation of Epidermal Growth Factor-Responsive Neural Stem Cell Progeny into the Murine Central Nervous System Methods in Neurosciences. 21: 281-293. DOI: 10.1016/B978-0-12-185291-7.50023-0  0.36
1993 Hammang JP, Behringer RR, Baetge EE, Palmiter RD, Brinster RL, Messing A. Oncogene expression in retinal horizontal cells of transgenic mice results in a cascade of neurodegeneration. Neuron. 10: 1197-209. PMID 8391281 DOI: 10.1016/0896-6273(93)90067-2  0.354
1993 Hammang JP, Baetge EE, Messing A. Immortalized Neuronal and Neuroendocrine Cell Lines by Targeted Oncogenesis in Transgenic Mice Using the PNMT Promoter Neuroprotocols. 3: 176-183. DOI: 10.1006/Ncmn.1993.1052  0.379
1992 Fung KM, Messing A, Lee VM, Trojanowski JQ. A novel modification of the avidin-biotin complex method for immunohistochemical studies of transgenic mice with murine monoclonal antibodies. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 40: 1319-28. PMID 1506669 DOI: 10.1177/40.9.1506669  0.598
1992 Messing A, Behringer RR, Hammang JP, Palmiter RD, Brinster RL, Lemke G. P0 promoter directs expression of reporter and toxin genes to Schwann cells of transgenic mice. Neuron. 8: 507-20. PMID 1372510 DOI: 10.1016/0896-6273(92)90279-M  0.456
1991 Hammang JP, Messing A. Immortalized retinal neurons used as immunogen for the generation of cell-specific antisera. Brain Research. 556: 85-94. PMID 1718559 DOI: 10.1016/0006-8993(91)90550-F  0.342
1990 Messing A, Behringer RR, Slapak JR, Lemke G, Palmiter RD, Brinster RL. Insertional mutation at the ld locus (again!) in a line of transgenic mice. Mouse Genome. 87: 107. PMID 25346577  0.303
1990 Hammang JP, Baetge EE, Behringer RR, Brinster RL, Palmiter RD, Messing A. Immortalized retinal neurons derived from SV40 T-antigen-induced tumors in transgenic mice. Neuron. 4: 775-82. PMID 2344410 DOI: 10.1016/0896-6273(90)90204-S  0.382
1990 Messing A. Modeling Schwann cell diseases in transgenic mice. Annals of the New York Academy of Sciences. 605: 325-31. PMID 1702605 DOI: 10.1111/J.1749-6632.1990.Tb42406.X  0.446
1989 Dyer KR, Messing A. Peripheral neuropathy associated with functional islet cell adenomas in SV40 transgenic mice. Journal of Neuropathology and Experimental Neurology. 48: 399-412. PMID 2543797 DOI: 10.1097/00005072-198907000-00002  0.424
1989 Messing A, Behrinqer RR, Hammang JP, Lemke G, Brinster RL, Palmiter RD. SCHWANN-CEIL-SPECIFIC GENE EXPRESSION IN TRANSGENIC MICE Journal of Neuropathology and Experimental Neurology. 48: 347. DOI: 10.1097/00005072-198905000-00144  0.43
1988 Behringer RR, Peschon JJ, Messing A, Gartside CL, Hauschka SD, Palmiter RD, Brinster RL. Heart and bone tumors in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America. 85: 2648-52. PMID 2833748 DOI: 10.1073/Pnas.85.8.2648  0.342
1987 Ornitz DM, Hammer RE, Messing A, Palmiter RD, Brinster RL. Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice. Science (New York, N.Y.). 238: 188-93. PMID 2821617 DOI: 10.1126/Science.2821617  0.33
1987 Messing A, Pinkert CA, Palmiter RD, Brinster RL. DEVELOPMENTAL STUDY OF SV*** GENE EXPRESSION IN TRANSGENIC MICE WITH DISORDERS OF CHOROID PLEXUS, THYMUS AND KIDNEY Journal of Neuropathology and Experimental Neurology. 46: 373. DOI: 10.1097/00005072-198705000-00132  0.4
1985 Messing A, Stieber A, Gonatas NK. Resolution of diaminobenzidine for the detection of horseradish peroxidase on surfaces of cultured cells. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 33: 837-9. PMID 3894500 DOI: 10.1177/33.8.3894500  0.494
1985 Messing A, Chen HY, Palmiter RD, Brinster RL. Peripheral neuropathies, hepatocellular carcinomas and islet cell adenomas in transgenic mice. Nature. 316: 461-3. PMID 2991772 DOI: 10.1038/316461A0  0.421
1985 Palmiter RD, Chen HY, Messing A, Brinster RL. SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumours in transgenic mice. Nature. 316: 457-60. PMID 2991771 DOI: 10.1038/316457A0  0.355
1984 Messing A, Bizzini B, Gonatas NK. Concanavalin A inhibits nicotinic acetylcholine receptor function in cultured chick ciliary ganglion neurons. Brain Research. 303: 241-9. PMID 6331572 DOI: 10.1016/0006-8993(84)91210-1  0.496
1984 Brinster RL, Chen HY, Messing A, van Dyke T, Levine AJ, Palmiter RD. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell. 37: 367-79. PMID 6327063 DOI: 10.1016/0092-8674(84)90367-2  0.371
1983 Messing A, Gonatas NK. Extra-synaptic localization of alpha-bungarotoxin receptors in cultured chick ciliary ganglion neurons. Brain Research. 269: 172-6. PMID 6191837 DOI: 10.1016/0006-8993(83)90977-0  0.513
Show low-probability matches.